Senti Biosciences's total assets for Q1 2025 were $82.78M, a decrease of -15.40% from the previous quarter. SNTI total liabilities were $44.92M for the fiscal quarter, a -37.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.